Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

Publications found: 410

Sort by:

Global Agomelatine Tablets Market Growth 2026-2032

US$ 3,660.00

The global Agomelatine Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Agomel...

August 2026 82 pages

Global Selective 5-HT And Norepinephrine Reuptake Inhibitors Market Growth 2026-2032

US$ 3,660.00

The global Selective 5-HT And Norepinephrine Reuptake Inhibitors market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 203...

August 2026 136 pages

Global Selective Norepinephrine Reuptake Inhibitor (NRI) Market Growth 2026-2032

US$ 3,660.00

The global Selective Norepinephrine Reuptake Inhibitor (NRI) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. U...

August 2026 134 pages

Global Selective 5-HT Reuptake Inhibitors (SSRI) Market Growth 2026-2032

US$ 3,660.00

The global Selective 5-HT Reuptake Inhibitors (SSRI) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United St...

August 2026 117 pages

Global Autonomic Nervous System Healthcare Product Market 2026 by Company, Regions, Type and Application, Forecast to 2032

US$ 3,480.00

According to our (Global Info Research) latest study, the global Autonomic Nervous System Healthcare Product market size was valued at US$ 134960 million in 2025 and is forecast to a readjusted size o...

August 2026 125 pages

2026-2031 Global Circadian Rhythm Sleep Disorders Drug Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Circadian Rhythm Sleep Disorders Drug market size will grow from 726.32 Million USD in 2025 to 1085.81 Million USD by 2031, at an estimated CAGR of 6.93%. The base year...

August 2026 150 pages

2026-2031 Global Chemotherapy Induced Peripheral Neuropathy Treatment Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Chemotherapy Induced Peripheral Neuropathy Treatment market size will grow from 1921.53 Million USD in 2025 to 2956.42 Million USD by 2031, at an estimated CAGR of 7.45%...

August 2026 137 pages

2026-2031 Global 2-Propylpentanoic Acid Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the 2-Propylpentanoic Acid market size will grow from 157.64 Million USD in 2025 to 201.59 Million USD by 2031, at an estimated CAGR of 4.18%. The base year considered for t...

August 2026 129 pages

2026-2031 Global Carbamazepine API Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Carbamazepine API market size will grow from 208.08 Million USD in 2025 to 285.83 Million USD by 2031, at an estimated CAGR of 5.43%. The base year considered for the st...

August 2026 137 pages

2026-2031 Global Cognitive Impairment Disorders Treatment Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Cognitive Impairment Disorders Treatment market size will grow from 180.01 Million USD in 2025 to 283.46 Million USD by 2031, at an estimated CAGR of 7.86%. The base yea...

August 2026 147 pages

2026-2031 Global Duloxetine Hydrochloride API Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Duloxetine Hydrochloride API market size will grow from 246.36 Million USD in 2025 to 350.5 Million USD by 2031, at an estimated CAGR of 6.05%. The base year considered...

August 2026 133 pages

2026-2031 Global Valproic Acid Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Valproic Acid market size will grow from 141.64 Million USD in 2025 to 188.52 Million USD by 2031, at an estimated CAGR of 4.88%. The base year considered for the study...

August 2026 143 pages

2026-2031 Global Zaleplon API Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Zaleplon API market size will grow from 205.23 Million USD in 2025 to 290.29 Million USD by 2031, at an estimated CAGR of 5.95%. The base year considered for the study i...

August 2026 144 pages

2026-2031 Global Divalproex Sodium Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Divalproex Sodium market size will grow from 2505.46 Million USD in 2025 to 3783.56 Million USD by 2031, at an estimated CAGR of 7.11%. The base year considered for the...

August 2026 152 pages

2026-2031 Global Infantile Spasms Therapeutics Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Infantile Spasms Therapeutics market size will grow from 155.04 Million USD in 2025 to 197.88 Million USD by 2031, at an estimated CAGR of 4.15%. The base year considere...

August 2026 142 pages

2026-2031 Global Perphenazine Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Perphenazine market size will grow from 105.35 Million USD in 2025 to 132.97 Million USD by 2031, at an estimated CAGR of 3.96%. The base year considered for the study i...

August 2026 144 pages

2026-2031 Global Alzheimer's Disease Drug Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Alzheimer's Disease Drug market size will grow from 3801.54 Million USD in 2025 to 4183.69 Million USD by 2031, at an estimated CAGR of 1.61%. The base year considered f...

August 2026 136 pages

2026-2031 Global Depression Drugs Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Depression Drugs market size will grow from 18311.3 Million USD in 2025 to 22455.36 Million USD by 2031, at an estimated CAGR of 3.46%. The base year considered for the...

August 2026 133 pages

2026-2031 Global Bipolar Disorder Drugs and Treatment Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the Bipolar Disorder Drugs and Treatment market size will grow from 146.74 Million USD in 2025 to 181.38 Million USD by 2031, at an estimated CAGR of 3.6%. The base year con...

August 2026 128 pages

Neurodegenerative Disease Market Size, Share and Growth Outlook 2026: By Indication, By Drug Class, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neurodegenerative Disease Market size is forecast to increase from $67.27 Billion in 2026 to $119.97 Billion in 2034 at a CAGR of 7.5% between 2026 and 2034. The Neurodegenerative Disease m...

July 2026 190 pages

Neuropathic Pain Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neuropathic Pain Market size is forecast to increase from $8.76 Billion in 2026 to $13.75 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034. The Neuropathic Pain market report provide...

July 2026 190 pages

Pregabalin Market Size, Share and Growth Outlook 2026: By Dosage Form (Oral Capsule, Oral Solution, Oral Tablet, Extended Release), By Application, By Drug Class, By Distribution Channel, By End User, Companies to 2034.

US$ 3,482.00

The global Pregabalin Market size is forecast to increase from $1.56 Billion in 2026 to $2.18 Billion in 2034 at a CAGR of 4.3% between 2026 and 2034. The Pregabalin market report provides detailed an...

July 2026 190 pages

Rare Neurological Disease Treatment Market Size, Share and Growth Outlook 2026: By Therapy, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Rare Neurological Disease Treatment Market size is forecast to increase from $25.49 Billion in 2026 to $64.94 Billion in 2034 at a CAGR of 12.4% between 2026 and 2034. The Rare Neurological...

July 2026 190 pages

Seasonal Affective Disorder Therapeutics Market Size, Share and Growth Outlook 2026: By Mode of Therapy, By Disorder Type, By Seasonal Pattern, By End-User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Seasonal Affective Disorder Therapeutics Market size is forecast to increase from $1.11 Billion in 2026 to $1.63 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034. The Seasonal Affect...

July 2026 190 pages

Skin Tears Treatment Market Size, Share and Growth Outlook 2026: By Product Type, By End-User, Companies to 2034

US$ 3,482.00

The global Skin Tears Treatment Market size is forecast to increase from $543.45 Million in 2026 to $892.67 Million in 2034 at a CAGR of 6.4% between 2026 and 2034. The Skin Tears Treatment market rep...

July 2026 190 pages

Substance Abuse Treatment Market Size, Share and Growth Outlook 2026: By Addiction, By Treatment Type, By Care Setting, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Substance Abuse Treatment Market size is forecast to increase from $122.94 Billion in 2026 to $206.23 Billion in 2034 at a CAGR of 6.68% between 2026 and 2034. The Substance Abuse Treatment...

July 2026 190 pages

Tardive Dyskinesia (TD) Treatment Market Size, Share and Growth Outlook 2026: By Drug (Valbenazine (Ingrezza), Deutetrabenazine (Austedo), Tetrabenazine, Other Off-Label Therapeutics), By Indication, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Tardive Dyskinesia (TD) Treatment Market size is forecast to increase from $2.82 Billion in 2026 to $4.1 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034. The Tardive Dyskinesia Trea...

July 2026 190 pages

Tourette Syndrome Treatment Market Size, Share and Growth Outlook 2026: By Treatment (Pharmacotherapy, Non-Pharmacological Therapies), By Route of Administration, By Patient Age Group, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Tourette Syndrome Treatment Market size is forecast to increase from $2.62 Billion in 2026 to $4.43 Billion in 2034 at a CAGR of 6.79% between 2026 and 2034. The Tourette Syndrome Treatment...

July 2026 190 pages

Obsessive-Compulsive Disorder (OCD) Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Severity, By Obsession, By Patient Population, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Obsessive-Compulsive Disorder (OCD) Drugs Market size is forecast to increase from $1.65 Billion in 2026 to $3.64 Billion in 2034 at a CAGR of 10.4% between 2026 and 2034. The Obsessive-Com...

July 2026 190 pages

Insomnia Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Receptor Antagonists, Melatonin Antagonists, Other Therapeutics), By Sales, Companies to 2034

US$ 3,482.00

The global Insomnia Therapeutics Market size is forecast to increase from $3.34 Billion in 2026 to $4.8 Billion in 2034 at a CAGR of 4.64% between 2026 and 2034. The Insomnia Therapeutics market repor...

July 2026 190 pages

Migraine Drugs Market Size, Share and Growth Outlook 2026: By Treatment Type, By Therapeutic Class, By Route of Administration, By Age Group, By Availability, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Migraine Drugs Market size is forecast to increase from $8.26 Billion in 2026 to $16.96 Billion in 2034 at a CAGR of 9.41% between 2026 and 2034. The Migraine Drugs market report provides d...

July 2026 190 pages

Multi-infarct Dementia Market Size, Share and Growth Outlook 2026: By Treatment Type (Pharmacological Therapeutics, Non-Pharmacological Interventions), By Drug Class, By Diagnostics and Assessment, By End-User, Companies to 2034.

US$ 3,482.00

The global Multi-infarct Dementia Market size is forecast to increase from $2.24 Billion in 2026 to $3.01 Billion in 2034 at a CAGR of 3.76% between 2026 and 2034. The Multi-infarct Dementia market re...

July 2026 190 pages

Neuralgia Treatment Market Size, Share and Growth Outlook 2026: By Treatment Type (Medications, Surgical Procedures, Non-Invasive Therapies), By Application, By End-User, Companies to 2034.

US$ 3,482.00

The global Neuralgia Treatment Market size is forecast to increase from $2.32 Billion in 2026 to $3.95 Billion in 2034 at a CAGR of 6.89% between 2026 and 2034. The Neuralgia Treatment market report p...

July 2026 190 pages

Neurometabolic Disorders Market Size, Share and Growth Outlook 2026: By Disorder Type, By Treatment, By Route of Administration, By End-User, Companies to 2034

US$ 3,482.00

The global Neurometabolic Disorders Market size is forecast to increase from $8.95 Billion in 2026 to $16.21 Billion in 2034 at a CAGR of 7.71% between 2026 and 2034. The Neurometabolic Disorders mark...

July 2026 190 pages

Psychedelic Drugs Market Size, Share and Growth Outlook 2026: By Drug Type, By Source, By Application, By Route of Administration, By End-use Setting, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Psychedelic Drugs Market size is forecast to increase from $3.23 Billion in 2026 to $9.4 Billion in 2034 at a CAGR of 14.28% between 2026 and 2034. The Psychedelic Drugs market report provi...

July 2026 190 pages

Schizoaffective Disorders Treatment Market Size, Share and Growth Outlook 2026: By Therapeutic Class, By Route of Administration, By Distribution Channel, By End User, Companies to 2034

US$ 3,482.00

The global Schizoaffective Disorders Treatment Market size is forecast to increase from $5.04 Billion in 2026 to $7.85 Billion in 2034 at a CAGR of 5.69% between 2026 and 2034. The Schizoaffective Dis...

July 2026 190 pages

Spinal Muscular Atrophy Therapeutics Market Size, Share and Growth Outlook 2026: By Disease Type (Type I, Type II, Type III, Type IV), By Drug Type, By Route of Administration, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Spinal Muscular Atrophy Therapeutics Market size is forecast to increase from $5.49 Billion in 2026 to $20.08 Billion in 2034 at a CAGR of 17.6% between 2026 and 2034. The Spinal Muscular A...

July 2026 190 pages

Infantile Spasms Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Category, By Mechanism of Action, By Route of Administration, By Etiology, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Infantile Spasms Therapeutics Market size is forecast to increase from $4.25 Billion in 2026 to $5.73 Billion in 2034 at a CAGR of 3.8% between 2026 and 2034. The Infantile Spasms Therapeut...

July 2026 190 pages

Lennox-Gastaut Syndrome (LGS) Treatment Market Size, Share and Growth Outlook 2026: By Drug, By Route of Administration, By Therapeutic Use, By Age Cohort, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Lennox-Gastaut Syndrome (LGS) Treatment Market size is forecast to increase from $3.54 Billion in 2026 to $5 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034. The Lennox-Gastaut Synd...

July 2026 190 pages

Multiple Sclerosis Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Route of Administration, By Disease Focus, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Multiple Sclerosis Drugs Market size is forecast to increase from $30.89 Billion in 2026 to $49.61 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034. The Multiple Sclerosis Drugs mark...

July 2026 190 pages

Narcolepsy Drugs Market Size, Share and Growth Outlook 2026: By Treatment Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), By Product Type, By End-User, Companies to 2034.

US$ 3,482.00

The global Narcolepsy Drugs Market size is forecast to increase from $4.52 Billion in 2026 to $8.43 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034. The Narcolepsy Drugs market report provides...

July 2026 190 pages

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, Share and Growth Outlook 2026: By Treatment, By Dosage Form, By Diagnosis, By End-User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market size is forecast to increase from $725.08 Million in 2026 to $1209.05 Million in 2034 at a CAGR of 6.6% between 2026 and 2034. The Neur...

July 2026 190 pages

Pediatric Epilepsy Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Generation, By Disease, By Seizure Type, By Route of Administration, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Pediatric Epilepsy Therapeutics Market size is forecast to increase from $13.9 Billion in 2026 to $22.83 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034. The Pediatric Epilepsy Ther...

July 2026 190 pages

Peripheral Neuropathy Treatment Market Size, Share and Growth Outlook 2026: By Cause, By Treatment Modality, By Drug Class, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Peripheral Neuropathy Treatment Market size is forecast to increase from $2.19 Billion in 2026 to $3.11 Billion in 2034 at a CAGR of 4.5% between 2026 and 2034. The Peripheral Neuropathy Tr...

July 2026 190 pages

Progressive Supranuclear Palsy Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Type, By Phenotype Variant, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Progressive Supranuclear Palsy Therapeutics Market size is forecast to increase from $10.74 Billion in 2026 to $16.61 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034. The Progressiv...

July 2026 190 pages

Restless Legs Syndrome Market Size, Share and Growth Outlook 2026: By Type (Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome), By Treatment Type, Companies to 2034.

US$ 3,482.00

The global Restless Legs Syndrome Market size is forecast to increase from $730.04 Million in 2026 to $983.84 Million in 2034 at a CAGR of 3.8% between 2026 and 2034. The Restless Legs Syndrome market...

July 2026 190 pages

Schizophrenia Therapeutics Market Size, Share and Growth Outlook 2026: By Therapeutic Class (Second-Generation Antipsychotics, Third-Generation Antipsychotics, First-Generation Antipsychotics, Generics), By Treatment Route, Companies to 2034.

US$ 3,482.00

The global Schizophrenia Therapeutics Market size is forecast to increase from $8.94 Billion in 2026 to $13.62 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034. The Schizophrenia Therapeutics m...

July 2026 190 pages

Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Share and Growth Outlook 2026: By Drug Type (Sertraline, Fluoxetine, Escitalopram, Paroxetine, Citalopram, Fluvoxamine), By Indication, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Selective Serotonin Reuptake Inhibitors (SSRIs) Market size is forecast to increase from $5.1 Billion in 2026 to $7.09 Billion in 2034 at a CAGR of 4.2% between 2026 and 2034. The Selective...

July 2026 190 pages

Sleep Apnea Implants Market Size, Share and Growth Outlook 2026: By Product, By Indication, By End User, Companies to 2034

US$ 3,482.00

The global Sleep Apnea Implants Market size is forecast to increase from $570.61 Million in 2026 to $1782.27 Million in 2034 at a CAGR of 15.3% between 2026 and 2034. The Sleep Apnea Implants market r...

July 2026 190 pages

Stroke Therapeutics Market Size, Share and Growth Outlook 2026: By Class of Therapeutics, By Stroke Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Stroke Therapeutics Market size is forecast to increase from $5.83 Billion in 2026 to $11.03 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034. The Stroke Therapeutics market report p...

July 2026 190 pages